Form 4: Bausch Health Director Acquires Shares

Bausch Health Companies Inc. Director Sandra Leung acquired 5,946 restricted share units, reflecting compensation for board service.

Summary

• Director Sandra Leung acquired 5,946 restricted share units (RSUs) on March 31, 2026.
• These RSUs were issued in lieu of cash compensation for her service on the Board of Directors for the quarter ending March 31, 2026.
• Each RSU represents a contingent right to receive one common share of Bausch Health Companies Inc.
• Following this transaction, Ms. Leung beneficially owns 44,354 common shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine compensation transaction for a director rather than a significant strategic or financial event.

Positives

• Director compensation in the form of equity aligns management interests with shareholders.
• The issuance of RSUs indicates continued engagement and commitment from board members.

Future Outlook

The filing does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that the issuance of Restricted Share Units (RSUs) as a form of director compensation is a common practice in the pharmaceutical and healthcare industry, aiming to retain experienced board members and align their interests with long-term company performance.

Stakeholder Impact

• Shareholders: The issuance of RSUs is a form of compensation, which can impact dilution if shares are issued upon vesting. However, it also aligns director interests with long-term shareholder value.

Key Dates

Keywords

Bausch Health Companies, BHC, Form 4, Insider Trading, Restricted Share Units, Director Compensation, Beneficial Ownership